Hexarelin

Description

Hexarelin is a synthetic ghrelin analog that stimulates growth hormone production, primarily studied for its effects on body composition and recovery. Research indicates additional benefits like neuroprotection and cardioprotection.

Overview

Hexarelin, also known as Examorelin, is a synthetic peptide developed in the 1980s with the aim of creating a selective growth hormone secretagogue. Unlike some other GHS compounds, Hexarelin was designed to specifically increase growth hormone release without significantly altering sex hormone, insulin, or glucagon levels. Initial studies demonstrated its sustained action compared to similar peptides and its ability to increase lean body mass in animal models without receptor desensitization. Beyond its well-established role in stimulating growth hormone, recent research has uncovered a broader spectrum of potential therapeutic applications for Hexarelin. Investigations highlight its neuroprotective capabilities, suggesting that it can mitigate brain inflammation and promote the generation of new neurons in the hippocampus, potentially offering benefits for neurodegenerative conditions. Additionally, Hexarelin has shown promising cardioprotective effects, improving cardiac muscle contractility, protecting against ischemic damage, and enhancing cardiac output. Hexarelin's impact on growth hormone levels is particularly relevant as natural growth hormone production declines with age. This decline contributes to various age-related issues, including reduced collagen synthesis, impaired muscle repair, decreased bone density, and altered fat distribution. By safely elevating growth hormone, Hexarelin holds promise for addressing these concerns and improving overall metabolic health. Studies have indicated its role in improving recovery from physical stress, aiding in fat loss by enhancing insulin sensitivity and fat metabolism, and supporting cardiovascular function by improving myocardial efficiency and potentially reversing atherosclerosis. Clinical trials have further explored Hexarelin's diverse effects. Research has demonstrated its potential in muscle preservation, particularly in mitigating muscle wasting (cachexia) associated with conditions like cancer and chemotherapy. It appears to achieve this by improving mitochondrial function, reducing inflammation, and regulating cell turnover. Additionally, studies have shown Hexarelin's ability to reduce triglyceride accumulation in fat cells and upregulate genes involved in fat metabolism, suggesting its utility in weight management strategies. Its neuroprotective properties have also been investigated in models of neurodegenerative diseases, showing promise in improving cell survival and reducing inflammation.

Mechanism of Action

Hexarelin functions as a growth hormone secretagogue by mimicking the endogenous hormone ghrelin. It achieves its effects by binding to the ghrelin/growth hormone secretagogue receptor (GHS-R), thereby stimulating the pituitary gland to release growth hormone. While primarily influencing growth hormone, hexarelin also exhibits a dose-dependent impact on the release of prolactin, adrenocorticotropic hormone, and cortisol.

Benefits

• •Improved body composition
• •Enhanced recovery from injury and exercise
• •Neuroprotective effects
• •Cardioprotective properties
• •Increased insulin sensitivity
• •Supports fat loss

Dosing Notes

A typical daily dose for research purposes is 300 mcg, divided into three separate 100 mcg subcutaneous injections administered throughout the day (morning, midday, and night). This split dosing regimen is recommended due to Hexarelin's relatively short half-life, ensuring consistent growth hormone elevation and minimizing the risk of adverse effects associated with a single large dose. Cycling protocols often involve 12 weeks of administration followed by a 4-week break to prevent potential receptor desensitization and allow the body's natural growth hormone production to regulate.

Reported Side Effects

• •Water retention
• •Increased cortisol levels (at high doses)
• •Increased prolactin levels (at high doses)
• •Fatigue or lethargy
• •Pain at injection site
• •Redness at injection site
• •Swelling at injection site
• •Bruising at injection site
• •Infection at injection site

Safety Notes

While generally well-tolerated in research settings, Hexarelin is not FDA-approved for human use. High doses may lead to elevated levels of cortisol, adrenocorticotropic hormone (ACTH), and prolactin. Potential side effects at the injection site include pain, redness, swelling, bruising, and a low risk of infection. Long-term use without cycling may lead to a temporary desensitization of endogenous growth hormone production, though this effect appears reversible after a break from the peptide.

Commonly Stacked With

Scientific References